Related Experiment Videos
[Ambulatory treatment of erectile dysfunction]
1Urologische Universitätsklinik beider Basel.
Therapeutische Umschau. Revue Therapeutique
|July 11, 1998
Summary
Current erectile dysfunction treatments like injections and vacuum devices offer alternatives but lack spontaneity. New oral medications are anticipated to improve patient outcomes and treatment simplicity.
Area of Science:
- Urology
- Andrology
- Sexual Medicine
Context:
- Erectile dysfunction (ED) management in Europe relies on intracavernous injections and vacuum constriction devices.
- Commonly used intracavernous agents include papaverine, alprostadil, and phentolamine, with dose-dependent and agent-specific response characteristics.
Purpose:
- To review current therapeutic alternatives for erectile dysfunction.
- To discuss the efficacy, limitations, and patient acceptance of various ED treatments.
- To highlight the need for refined diagnostic processes and minimally invasive treatments.
Summary:
- Intracavernous injections and vacuum devices are established ED treatments, but they impact spontaneity.
- The Medicated Urethral System for Erection (MUSE) offers a user-friendly alternative but with lower efficacy than injections.
- The development of oral treatments like Sildenafil is highly anticipated by patients and physicians for improved ED management.
Impact:
- The introduction of new oral therapies is expected to enhance patient satisfaction and treatment convenience.
- Refined diagnostic approaches are crucial for tailoring the least invasive and most effective ED treatments.
- Future advancements aim to balance efficacy with minimal side effects and improved spontaneity in ED management.